Show more

Start AI Chat

Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$3.86

Open

$3.78

Volume

68,297

Day Range

$3.77 - $3.96

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
CNSide (CNSide) (Tumor Cell Detection) Details Leptomeningeal Metastases	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REYOBIQ (Rhenium Re186 Obisbemeda) Details Glioblastoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REYOBIQ (Rhenium Re186 Obisbemeda) Details Leptomeningeal Metastases (LM)	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REYOBIQ (Rhenium Re186 Obisbemeda) Details Lung cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REYOBIQ (Rhenium Re186 Obisbemeda) Details Supratentorial recurrent, refractory, or progressive high-grade glioma (HGG) and ependymoma (pediatric patients)	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.